Volume 32; Issue Supplement

Main
Liver International
Volume 32; Issue Supplement

Liver International

Volume 32; Issue Supplement

1

Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

Tarik Asselah, Patrick Marcellin

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 1000 KB

english, 2012

2

Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders

Bruce R. Bacon, Omer Khalid

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 199 KB

english, 2012

3

New targets for antiviral therapy of chronic hepatitis C

Sandra Bühler, Ralf Bartenschlager

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 221 KB

english, 2012

4

Future treatment of patients with HCV cirrhosis

Marc Bourlière, Asma Khaloun, Claire Wartelle-Bladou, Valérie Oules, Isabelle Portal, Souad Benali, Xavier Adhoute, Paul Castellani

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 391 KB

english, 2012

5

2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines

Vincenza Calvaruso, Antonio Craxì

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 144 KB

english, 2012

6

The future for the treatment of genotype 4 chronic hepatitis C

G. Esmat, M. El Raziky, M. El Kassas, M. Hassany, M.E. Gamil

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 122 KB

english, 2012

7

Treatment of chronic hepatitis C – are interferons really necessary?

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 112 KB

english, 2012

8

Barriers to hepatitis C treatment

Christopher E. McGowan, Michael W. Fried

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 144 KB

english, 2012

9

Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice

Christophe Hézode

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 305 KB

english, 2012

10

Telaprevir user's guide

Ann Marie Liapakis, Ira Jacobson

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 321 KB

english, 2012

11

Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 114 KB

english, 2012

12

What's new in HCV genotype 2 treatment

Alessandra Mangia, Leonardo Mottola

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 122 KB

english, 2012

13

The role of ribavirin in direct acting antiviral drug regimens for chronic hepatitis C

Virginia Clark, David R. Nelson

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 282 KB

english, 2012

14

IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?

Donald M. Jensen, Stanislas Pol

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 120 KB

english, 2012

15

Response-guided and -unguided treatment of chronic hepatitis C

K. Rajender Reddy, Frederick Lin, Fabien Zoulim

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 146 KB

english, 2012

16

Hepatitis C virus treatment pre- and post-liver transplantation

Bruno Roche, Didier Samuel

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 188 KB

english, 2012

17

Treatment of patients with genotype 3 chronic hepatitis C- current and future therapies

Shiv K. Sarin, Chandan K. N. Kumar

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 121 KB

english, 2012

18

Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?

Philippe Halfon, Christoph Sarrazin

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 752 KB

english, 2012

19

Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon and ribavirin: ‘Lead-in or no lead-in’?

Graham R. Foster, Lawrence D. Serfaty

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 100 KB

english, 2012

20

Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

Mitchell L. Shiffman, Rafael Esteban

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 319 KB

english, 2012

21

Hepatitis C virus-human immunodeficiency virus coinfection

Mark S. Sulkowski

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 190 KB

english, 2012

22

Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders

Nicole Forestier, Stefan Zeuzem

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 806 KB

english, 2012

23

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1

Michael P. Manns, Antoaneta A. Markova, Beatriz Calle Serrano, Markus Cornberg

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 157 KB

english, 2012

24

Towards the eradication of hepatitis C virus

Patrick Marcellin, Tarik Asselah

Journal:

Liver International

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012